Header

UZH-Logo

Maintenance Infos

Primary immunodeficiencies: 2009 update


Notarangelo, L D; Fischer, A; Geha, R S; Casanova, J-L; Chapel, H; Conley, M E; Cunningham-Rundles, C; Etzioni, A; Hammartröm, L; Nonoyama, S; Ochs, H D; Puck, J; Roifman, C; Seger, R; Wedgwood, J (2009). Primary immunodeficiencies: 2009 update. Journal of Allergy and Clinical Immunology, 124(6):1161-1178.

Abstract

More than 50 years after Ogdeon Bruton's discovery of congenital agammaglobulinemia, human primary immunodeficiencies (PIDs) continue to unravel novel molecular and cellular mechanisms that govern development and function of the human immune system. This report provides the updated classification of PIDs that has been compiled by the International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies after its biannual meeting in Dublin, Ireland, in June 2009. Since the appearance of the last classification in 2007, novel forms of PID have been discovered, and additional pathophysiology mechanisms that account for PID in human beings have been unraveled. Careful analysis and prompt recognition of these disorders is essential to prompt effective forms of treatment and thus to improve survival and quality of life in patients affected with PIDs.

Abstract

More than 50 years after Ogdeon Bruton's discovery of congenital agammaglobulinemia, human primary immunodeficiencies (PIDs) continue to unravel novel molecular and cellular mechanisms that govern development and function of the human immune system. This report provides the updated classification of PIDs that has been compiled by the International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies after its biannual meeting in Dublin, Ireland, in June 2009. Since the appearance of the last classification in 2007, novel forms of PID have been discovered, and additional pathophysiology mechanisms that account for PID in human beings have been unraveled. Careful analysis and prompt recognition of these disorders is essential to prompt effective forms of treatment and thus to improve survival and quality of life in patients affected with PIDs.

Statistics

Citations

Dimensions.ai Metrics
291 citations in Web of Science®
336 citations in Scopus®
516 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

3 downloads since deposited on 11 Mar 2010
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2009
Deposited On:11 Mar 2010 15:25
Last Modified:18 Feb 2018 00:02
Publisher:Elsevier
ISSN:0091-6749
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.jaci.2009.10.013
PubMed ID:20004777

Download